OviGenex, LLC

Startup
Summarized by Halo AI

OviGenex, LLC is a biotechnology company that manufactures high-purity, traceable ovine collagen (CollOvine™) for medical and research applications, offering a safer and culturally acceptable alternative to bovine and porcine-sourced collagen.

Founded & HQ
Rancho Dominguez, CA, USA
Company size
1-10 employees
Funding
~$49K
Activity highlights
Received FDA 510(k) clearances for CollOvine Wound Dressing in June 2025 and CollOvine Wound Powder in February 2026.

OviGenex, LLC is a biotechnology company that manufactures premium, high-purity ovine (sheep) collagen under the brand name CollOvine™. The company utilizes proprietary purification processes to extract collagen from veterinarian-controlled, disease-free Australian sheep skins, resulting in products that are fully traceable, TSE-free, and possess nearly undetectable endotoxin levels. CollOvine™ is produced in solution and powder formats for various research and medical applications, serving as a culturally acceptable and safer alternative to bovine or porcine-derived collagens. By focusing on stringent manufacturing standards, OviGenex provides specialized biomaterials that maintain native collagen structure and performance, catering to diverse needs in tissue culture, regenerative medicine, and wound care.

These products are essential for researchers and medical professionals who require reliable, repeatable outcomes in sensitive applications, such as 3D cell scaffolding, cell adhesion assays, and the management of chronic, exuding wounds. The company’s solutions, including specialized wound dressings and research-grade collagen, help maintain an optimal micro-environment for healing and scientific experimentation. OviGenex supports its clients by providing technical documentation, performance comparison data, and customized sample formulations, ensuring their materials meet rigorous purity standards for medical and laboratory use. By addressing global demand for safe, high-quality alternatives in healthcare and biotechnology, OviGenex enables advancements in medical devices and complex experimental methodologies.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.